However, the patterns of MAVS palmitoylation changes in SLE and their regulatory mechanisms remain unclear, necessitating further investigation into the expression changes of these enzymes in SLE patients and their regulatory mechanisms on MAVS activity (195–197). This evidence concerns the gene MAVS and systemic lupus erythematosus.